Last update May 1, 2022
Compatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
エソメプラゾール is Esomeprazole in Japanese.
Is written in other languages:エソメプラゾール is also known as
エソメプラゾール belongs to this group or family:
Main tradenames from several countries containing エソメプラゾール in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Esomeprazole is a proton pump inhibitor (PPI), S enantiomer of Omeprazole, with the same actions and uses. Indicated in the treatment of peptic ulcer and gastroesophageal reflux. Oral administration once daily.
Like omeprazole (Nava 2006), it is excreted in breast milk in clinically insignificant amounts (Saito 2020) and no problems have been observed in an infant whose mother have taken it. (Saito 2020)
Since it's neutralized by the acid pH of stomach, capsules with enteric coated granules are used. Because of this, it is thought that the small quantity of Esomeprazole that may reach the breast milk would be neutralized by infant's stomach. In addition, absorption is greatly decreased by the presence of food.
Esomeprazole has been used for treatment of newborn and premature infants. (Omari 2009)
Hyperprolactinemia and galactorrhea have been reported by the use of Esomeprazole. (Pipaliya 2016)
See below the information of this related product: